Research that Identifies
Undiscovered Value in the MicroCap Market


Zynex, Inc. Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC Filings

Report Link: Updated Research Report (Dated 3/01/2019)

Symbol: ZYXI
Analyst: Howard Halpern
Taglich Rating: Buy
Price Target: $8.00
Time Horizon: 12 Months
Rating Established: August 21, 2017
Price When Established: $1.08
Most Recent Report: March 1, 2019
Price When Issued: $4.96

What's New

New information will be posted soon...

Company Description

Zynex, Inc., headquartered in Lone Tree, Colorado provides FDA-cleared electrotherapy medical devices used for pain management and rehabilitation. The company is primarily focused on selling and marketing its NexWave and InWave electrotherapy product, as well as consumable supplies for electrotherapy products. The company operates two subsidiaries, Zynex Medical™, which provides electrotherapy devices and consumable products for home use and Zynex Monitoring Solutions™, which is developing a blood volume-monitoring device for use in hospitals and outpatient surgical centers.

Company Reports

Updated Research Report (Dated March 1, 2019)

Updated Research Report (Dated November 9, 2018)

Updated Research Report (Dated August 8, 2018)

Updated Research Report (Dated March 9, 2018)

Updated Research Report (Dated November 20, 2017)

Initial Research Report (Dated July 26, 2017)


Please view our current disclosure and disclaimer on our most recent research report.